CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-16 | Zakrzewski Joseph S Director | Option exercise · Stock Option (Right to Buy) | +100,000 | 138,542 | ||
| 2019-12-16 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise | +43,253 | $12.60 | $545K | 177,059 |
| 2019-12-16 | Berg Aaron CHIEF COMMERCIAL OFFICER | Sale | −43,253 | $25.46 | $1.1M | 133,806 |
| 2019-12-16 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Stock Option (Right to Buy) | −43,253 | 0 | ||
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Option exercise | +25,000 | $2.19 | $55K | 46,552 |
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Sale | −16,400 | $23.05 | $378K | 30,152 |
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Sale | −7,500 | $23.81 | $179K | 22,652 |
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Sale | −1,000 | $24.84 | $25K | 21,652 |
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Sale | −100 | $25.66 | $3K | 21,552 |
| 2019-12-16 | Kalb Michael Wayne SVP and CFO | Option exercise · Stock Option (Right to Buy) | +25,000 | 150,000 | ||
| 2019-11-19 | THERO JOHN F President and CEO | Sale | −274,454 | $22.65 | $6.2M | 2,342,285 |
| 2019-11-12 | Ekman Lars Director | Option exercise | +38,600 | $14.40 | $556K | 38,600 |
| 2019-11-12 | Ekman Lars Director | Sale | −38,600 | $19.35 | $747K | 0 |
| 2019-11-12 | Ekman Lars Director | Option exercise · Stock Option (Right to Buy) | −38,600 | 0 | ||
| 2019-11-11 | THERO JOHN F President and CEO | Sale | −433,805 | $17.05 | $7.4M | 2,658,480 |
| 2019-11-11 | THERO JOHN F President and CEO | Sale | −41,741 | $17.88 | $746K | 2,616,739 |
| 2019-11-05 | Ekman Lars Director | Option exercise | +6,400 | $14.40 | $92K | 6,400 |
| 2019-11-05 | Ekman Lars Director | Sale | −6,400 | $18.00 | $115K | 0 |
| 2019-11-05 | Ekman Lars Director | Option exercise · Stock Option (Right to Buy) | −6,400 | 38,600 | ||
| 2019-10-28 | THERO JOHN F President and CEO | Option exercise | +11,601 | $2.50 | $29K | 3,092,285 |
Page 60 of 67 · 1,339 trades